Key statistics
On Friday, Innate Pharma SA (IPHA:NSQ) closed at 1.71, 4.91% above its 52-week low of 1.63, set on Dec 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.75 |
|---|---|
| High | 1.76 |
| Low | 1.71 |
| Bid | 1.70 |
| Offer | 1.81 |
| Previous close | 1.73 |
| Average volume | 14.36k |
|---|---|
| Shares outstanding | 93.74m |
| Free float | 63.69m |
| P/E (TTM) | -- |
| Market cap | 164.68m USD |
| EPS (TTM) | -0.6472 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025
- Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
- Innate Pharma Releases Its 2026 Financial Calendar
- Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
- Innate Pharma to Present at Jefferies Global Healthcare Conference
- Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
- Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
More ▼
